Key facts
- Junction’s last known valuation is $90.0M (Mar 2025).
- It has raised $21.0M; the latest was Early Stage VC ($18.0M) in Mar 2025.
- Notable investors include Y Combinator, Gaingels, 20VC, Creandum, Point Nine Capital — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Junction
- ·The full record, as it builds
Funding rounds
No funding rounds for Junction are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Junction
Developer of a healthcare infrastructure platform intended to simplify application development and integration in the medical field. The company's tool facilitates the collection of health and fitness data, links with medical devices and a nationwide laboratory network, and enables remote patient monitoring while also providing automated workflows and compliance support to enhance efficiency, enabling developers to unify diverse data sources within a single system.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 26
- Website
- junction.com/
- Ownership
- Privately Held (backing)
Junction doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Junction shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Junction in its N-PORT filings yet. We sweep new filings monthly.